Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-046718

SVP & Chief Operating Officer sold 3,819 shares at $18.15 ($69,315)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nicholson John SVP & Chief Operating Officer 2019-08-16 Sale −3,819 $18.15 $69,315 162,759 D: show line 1 in the form
Open-market sales · 3,819 sh · avg $18.15 · $69,315
Loading xslF345X03/doc4.xml…